Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas R Jeffery

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of the Neurological Sciences|May 9, 2002
Early intervention with immunomodulatory agents in the treatment of multiple sclerosisDouglas R Jeffery
Journal of the Neurological Sciences|July 21, 2004
The argument against the use of cyclophosphamide and mitoxantrone in the treatment of multiple sclerosisDouglas R Jeffery
Neurology|December 30, 2004
Use of combination therapy with immunomodulators and immunosuppressants in treating multiple sclerosisDouglas R Jeffery
The New England Journal of Medicine|June 3, 2006
Natalizumab for relapsing multiple sclerosisDouglas R Jeffery
Expert Review of Neurotherapeutics|October 9, 2009
Use of adrenocorticosteroid hormones in the treatment of multiple sclerosisDouglas R Jeffery
Therapeutic Advances in Chronic Disease|January 24, 2013
Recent advances in treating multiple sclerosis: efficacy, risks and place in therapyDouglas R Jeffery
Neurology|December 30, 2004
Review of mitoxantrone in the treatment of multiple sclerosisDouglas R Jeffery, Robert Herndon
Core Evidence|April 7, 2011
Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosisDouglas R Jeffery, Emily Poole Pharr
Therapeutic Advances in Neurological Disorders|December 24, 2010
Chemotherapeutics in the treatment of multiple sclerosisBernd C Kieseier, Douglas R Jeffery
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|January 30, 2004
Treatment of Marburg variant multiple sclerosis with mitoxantroneDouglas R Jeffery, David S Lefkowitz, Jeffrey P Crittenden
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of the Neurological Sciences|May 9, 2002
Early intervention with immunomodulatory agents in the treatment of multiple sclerosisDouglas R Jeffery
Journal of the Neurological Sciences|July 21, 2004
The argument against the use of cyclophosphamide and mitoxantrone in the treatment of multiple sclerosisDouglas R Jeffery
Neurology|December 30, 2004
Use of combination therapy with immunomodulators and immunosuppressants in treating multiple sclerosisDouglas R Jeffery
The New England Journal of Medicine|June 3, 2006
Natalizumab for relapsing multiple sclerosisDouglas R Jeffery
Expert Review of Neurotherapeutics|October 9, 2009
Use of adrenocorticosteroid hormones in the treatment of multiple sclerosisDouglas R Jeffery
Therapeutic Advances in Chronic Disease|January 24, 2013
Recent advances in treating multiple sclerosis: efficacy, risks and place in therapyDouglas R Jeffery
Neurology|December 30, 2004
Review of mitoxantrone in the treatment of multiple sclerosisDouglas R Jeffery, Robert Herndon
Core Evidence|April 7, 2011
Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosisDouglas R Jeffery, Emily Poole Pharr
Therapeutic Advances in Neurological Disorders|December 24, 2010
Chemotherapeutics in the treatment of multiple sclerosisBernd C Kieseier, Douglas R Jeffery
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|January 30, 2004
Treatment of Marburg variant multiple sclerosis with mitoxantroneDouglas R Jeffery, David S Lefkowitz, Jeffrey P Crittenden
Pageof 3